Compound ID | 3446
Synonym(s): CJ-15801 | CJ15801
Class: CoA synthesis inhibitor
Spectrum of activity: | Gram-positive |
Details of activity: | Only active against Staphylococcus aureus; coenzyme A (CoA) synthesis inhibitor (mimics the native reaction intermediate inducing a tight-binding with enzyme) |
Description: | Natural product from Seimatosporium sp.; an antimetabolite of the vitamin synthesis pathway |
Institute where first reported: | Pfizer Pharmaceuticals, Inc. |
Year first mentioned: | 2001 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|